Announcements

Zura Bio Limited filed its Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the quarterly period ended June 30, 2026.

Enviri Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on August 11, 2026, announcing its earnings results for the second quarter ended June 30, 2026.

FS Bancorp, Inc. filed a Form 8-K with the SEC on August 11, 2026, under Item 7.01 Regulation FD Disclosure, reporting that company executives will attend the D.A. Davidson Western Bank Summit virtually on August 11-12, 2026, and providing investor materials presented at the …

Tango Therapeutics, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing results of operations and financial condition for the quarter ended June 30, 2026, via an attached press release.

Andrew Rees, Chief Executive Officer and Director of Crocs, Inc. (NASDAQ:CROX), filed a Form 4 on August 11, 2026, disclosing the sale of common stock across six separate transactions on August 7 and August 10, 2026, all conducted indirectly through the Rees Family Living …

Amir Schlachet, CEO and Director of Global-E Online Ltd. (NASDAQ:GLBE), filed a Form 4 on August 11, 2026, reporting the sale of 322 ordinary shares on August 10, 2026, executed pursuant to a Rule 10b5-1 trading plan.

Regency Centers Corporation and Regency Centers, L.P. filed a Form 8-K on August 11, 2026, disclosing under Item 7.01 that an updated investor presentation was made available through the company's investor relations website.